{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:34:57Z","timestamp":1787315697879,"version":"build-2736575974"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Pelvic lymph node dissection during standard radical cystectomy (stdRC) for muscle invasive bladder cancer is performed as separate templates. In the modernized en bloc radical cystectomy (mEbRC), the bladder is removed together with all its associated lymphatic tissue as one specimen. Our aim was to evaluate the oncological and surgical outcomes of mEbRC with a propensity-matched national cohort of stdRC cases. Methods: 935 patients (mEbRC: 214 and stdRC: 721) were eligible for analysis, and 1:2 propensity score matching was performed regressing mEbRC treatment on the variables age, gender, neoadjuvant chemotherapy, Charlson Comorbidity Index, lymph node metastases at final pathology, carcinoma in situ, and pT-stage. The primary outcome was recurrence-free survival (RFS). Secondary endpoints were overall survival (OS) and cancer-specific survival (CSS), survival for female patients. and perioperative measures. Results: There were no significant differences between the groups regarding complications, 30-day readmission rates, and 30- and 90-day mortality rates. In the propensity score matched groups, the 5-year RFS was 83% in the mEbRC group vs. 67% in the stdRC group (p &lt; 0.001), the CSS was 89% and 78% (p \u2264 0.001), and OS 81% vs. 68% (p &lt; 0.001) in the same groups, respectively. The results were confirmed by Cox regression analyses with hazard ratios ranging from 0.41 to 0.50 and p-values \u2264 0.001, favoring mEbRC. The 5-year OS for female patients was 86% for mEbRC and 60% for stdRC (p = 0.022). Conclusions: Performing mEbRC over stdRC might yield significantly better oncological outcomes, with equal survival rates for both genders.<\/jats:p>","DOI":"10.3390\/cancers17030404","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:46:29Z","timestamp":1737963989000},"page":"404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cModernized\u201d en Bloc Radical Cystectomy Versus Standard Radical Cystectomy: A Nationwide Multi-Institutional Propensity Score Matched Analysis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-9615","authenticated-orcid":false,"given":"Eirik","family":"Kj\u00f8bli","sequence":"first","affiliation":[{"name":"Department of Urology, St. Olav\u2019s University Hospital, 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-1901","authenticated-orcid":false,"given":"Erik Skaaheim","family":"Haug","sequence":"additional","affiliation":[{"name":"Department of Urology, Vestfold Hospital Trust, 3103 T\u00f8nsberg, Norway"},{"name":"Department of Clinical Medicine, University of Bergen, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7431-7895","authenticated-orcid":false,"given":"Christian","family":"Arstad","sequence":"additional","affiliation":[{"name":"Department of Urology, Akershus University Hospital, 1478 Nordbyhagen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kvaale","family":"Bergesen","sequence":"additional","affiliation":[{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Brennhovd","sequence":"additional","affiliation":[{"name":"Department of Urology, Oslo University Hospital, 0586 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Carlsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, 5009 Bergen, Norway"},{"name":"Department of Pathology, Vestfold Hospital Trust, 3103 T\u00f8nsberg, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Gharib-Alhaug","sequence":"additional","affiliation":[{"name":"Department of Urology, Oslo University Hospital, 0586 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigja","family":"Gudbrandsdottir","sequence":"additional","affiliation":[{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Julieb\u00f8-Jones","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, 5009 Bergen, Norway"},{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie N\u00f8ss","family":"Haugland","sequence":"additional","affiliation":[{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Karoline","family":"Karlsvik","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Olav\u2019s University Hospital, 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Urology, Troms\u00f8 University Hospital of North Norway, 9019 Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6598-8251","authenticated-orcid":false,"given":"Gunder Magne","family":"Lilleaasen","sequence":"additional","affiliation":[{"name":"Department of Urology, Akershus University Hospital, 1478 Nordbyhagen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"M\u00fbller","sequence":"additional","affiliation":[{"name":"Department of Urology, Akershus University Hospital, 1478 Nordbyhagen, Norway"},{"name":"Institute for Clinical Medicine, University of Oslo, 0372 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Lisbeth","family":"Plathan","sequence":"additional","affiliation":[{"name":"Department of Urology, Vestfold Hospital Trust, 3103 T\u00f8nsberg, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1572-2510","authenticated-orcid":false,"given":"Marius","family":"Roaldsen","sequence":"additional","affiliation":[{"name":"Department of Urology, Troms\u00f8 University Hospital of North Norway, 9019 Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, 5009 Bergen, Norway"},{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9328-2485","authenticated-orcid":false,"given":"Bernd Lukas Luca","family":"Schwenke","sequence":"additional","affiliation":[{"name":"Department of Urology, Akershus University Hospital, 1478 Nordbyhagen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Wahlqvist","sequence":"additional","affiliation":[{"name":"Department of Urology, Oslo University Hospital, 0586 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Wessel","sequence":"additional","affiliation":[{"name":"Department of Urology, Oslo University Hospital, 0586 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-4134","authenticated-orcid":false,"given":"Arne","family":"Wibe","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway"},{"name":"Department of Gastrointestinal Surgery, St. Olav\u2019s University Hospital, 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-4937","authenticated-orcid":false,"given":"Christian","family":"Beisland","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, 5009 Bergen, Norway"},{"name":"Department of Urology, Haukeland University Hospital, 5009 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"ref_1","unstructured":"Guidellines, E. (2024). Muscle-invasive and Metastatic Bladder Cancer. EAU Guidelines 2024, EAU Guidelines. Edn, EAU Annual Congress Paris."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Advanced Bladder Cancer Meta-analysis Collaboration (2003). Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet, 361, 1927\u20131934.","DOI":"10.1016\/S0140-6736(03)13580-5"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","article-title":"Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): An open-label, randomised, phase 3, non-inferiority trial","volume":"391","author":"Parekh","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial","volume":"75","author":"Gschwend","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa2401497","article-title":"Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer","volume":"391","author":"Lerner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1016\/j.urolonc.2017.06.061","article-title":"Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment","volume":"35","author":"Williams","year":"2017","journal-title":"Urol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.euf.2019.06.001","article-title":"Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy","volume":"7","author":"Krimphove","year":"2021","journal-title":"Eur. Urol. Focus."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0094-0143(21)01287-8","article-title":"Technique of radical cystectomy","volume":"8","author":"Skinner","year":"1981","journal-title":"Urol. Clin. North. Am."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Droller, M.J. (2001). Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer. Bladder Cancer: Current Diagnosis and Treatment, Humana Press.","DOI":"10.1007\/978-1-59259-097-1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.juro.2006.10.043","article-title":"Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer","volume":"177","author":"Stein","year":"2007","journal-title":"J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JU.0000000000002242","article-title":"Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases","volume":"207","author":"Mitra","year":"2022","journal-title":"J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Alsina","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_15","first-page":"471","article-title":"Total mesorectal excision for rectal cancer--what can be achieved by a national audit?","volume":"5","author":"Wibe","year":"2003","journal-title":"Color. Dis. Off. J. Assoc. Coloproctology Great Br. Irel."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3322\/canjclin.18.2.82","article-title":"Cancer of the colon: The influence of the no-touch isolation technic on survival rates","volume":"18","author":"Turnbull","year":"1968","journal-title":"CA Cancer J. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bco2.190","article-title":"En bloc radical cystectomy: An overview of the technique and oncological results","volume":"4","author":"Salvesen","year":"2023","journal-title":"BJUI Compass"},{"key":"ref_18","unstructured":"Health, N.D.o. (2024, October 09). The Cancer Pathways. Available online: https:\/\/www.helsenorge."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"D\u2019Andrea, V.D., Melnick, K., Yim, K., Ernandez, J., Onochie, N., Clinton, T.N., Steele, G.S., Preston, M.A., Kibel, A.S., and Mossanen, M. (2023). Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder Cancer. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216845"},{"key":"ref_20","unstructured":"Brierley, J.D. (2016). TNM Classification of Malignant Tumours, UICC. [8th ed.]."},{"key":"ref_21","unstructured":"(2024, October 09). The Cancer Registry of Norway. Available online: https:\/\/www.kreftregisteret.no\/en\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/cncr.22250","article-title":"Standardization of pelvic lymphadenectomy performed at radical cystectomy: Can we establish a minimum number of lymph nodes that should be removed?","volume":"107","author":"Koppie","year":"2006","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.urolonc.2014.01.017","article-title":"Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis","volume":"32","author":"Mandel","year":"2014","journal-title":"Urol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1001\/jama.2022.7393","article-title":"Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial","volume":"327","author":"Catto","year":"2022","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.ejso.2014.10.004","article-title":"Contemporary 90-day mortality rates after radical cystectomy in the elderly","volume":"40","author":"Schiffmann","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/JU.0000000000001071","article-title":"Trends in Management and Outcomes among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience","volume":"204","author":"Almassi","year":"2020","journal-title":"J. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: Long-term results in 1100 patients","volume":"61","author":"Hautmann","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/0284186X.2023.2228446","article-title":"Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland","volume":"62","author":"Nikulainen","year":"2023","journal-title":"Acta Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1097\/JS9.0000000000001675","article-title":"The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: Insights from a cohort study utilizing Chinese multicenter and SEER registries","volume":"110","author":"Liu","year":"2024","journal-title":"Int. J. Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/3\/404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:14Z","timestamp":1759919774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/3\/404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["cancers17030404"],"URL":"https:\/\/doi.org\/10.3390\/cancers17030404","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]}}}